TREA

79181453 - PLEXZYME

Follow

Information

  • Trademark
  • 79181453
  • Serial Number
    79181453
  • Registration Number
    5215651
  • Filing Date
    September 17, 2015
    9 years ago
  • Registration Date
    June 06, 2017
    7 years ago
  • Transaction Date
    February 14, 2024
    10 months ago
  • Status Date
    February 13, 2024
    10 months ago
  • Published for Opposition Date
    March 21, 2017
    7 years ago
  • Location Date
    February 13, 2024
    10 months ago
  • Status Code
    739
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    LAW, CHRISTOPHER M
  • Attorney Docket Number
    120776SPX003
    Attorney Name
    Mainak H. Mehta
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
5000
Mark Identification
PLEXZYME
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens for medical and veterinary purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits in this class consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants in this class for non-medical purposes; enzymes for industrial purposes, namely, for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; acids, namely, inorganic acids; organic acids for use in the biotechnology industry; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; chemicals used in environmental monitoring
  • GS0101: Surgical, medical and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; point of care medical devices for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; medical screening apparatus in this class for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy
Case File Event Statements
  • 2/13/2024 - 10 months ago
    42 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75
  • 2/13/2024 - 10 months ago
    41 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75A
  • 2/12/2024 - 10 months ago
    40 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 6/6/2023 - a year ago
    39 - TEAS SECTION 71 & 15 RECEIVED Type: ES75
  • 6/6/2022 - 2 years ago
    38 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 10/28/2017 - 7 years ago
    37 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 9/14/2017 - 7 years ago
    36 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 9/14/2017 - 7 years ago
    35 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/6/2017 - 7 years ago
    34 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/6/2017 - 7 years ago
    33 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/21/2017 - 7 years ago
    32 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/21/2017 - 7 years ago
    31 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/17/2017 - 7 years ago
    30 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 3/10/2017 - 7 years ago
    29 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/1/2017 - 7 years ago
    28 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 3/1/2017 - 7 years ago
    27 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 3/1/2017 - 7 years ago
    26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/13/2017 - 7 years ago
    25 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 2/10/2017 - 7 years ago
    24 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 2/1/2017 - 7 years ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/1/2017 - 7 years ago
    22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/1/2017 - 7 years ago
    21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/1/2017 - 7 years ago
    20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/1/2017 - 7 years ago
    19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/16/2016 - 8 years ago
    18 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 9/1/2016 - 8 years ago
    17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 9/1/2016 - 8 years ago
    16 - FINAL REFUSAL E-MAILED Type: GNFR
  • 9/1/2016 - 8 years ago
    15 - FINAL REFUSAL WRITTEN Type: CNFR
  • 8/16/2016 - 8 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/16/2016 - 8 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/16/2016 - 8 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 8/10/2016 - 8 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/27/2016 - 8 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/10/2016 - 8 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/10/2016 - 8 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/10/2016 - 8 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/9/2016 - 8 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/9/2016 - 8 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/9/2016 - 8 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/5/2016 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/5/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/4/2016 - 8 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR